Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$352,555
-$58,564 QoQ
Shares Held
14,641
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#2,007
of 2,826 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ZEVIN ASSET MANAGEMENT LLC holds $59,856,217 across 9 Drug Manufacturers - General names. PFE ranks #8 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
76,892 | $19,349,102 | |
| 2 | LLY |
ELI LILLY & Co
|
12,300 | $14,752,990 | |
| 3 | NVS |
Novartis AG
|
74,291 | $11,642,885 | |
| 4 | AZN |
Astrazeneca PLC
|
58,678 | $11,126,522 | |
| 5 | AMGN |
Amgen Inc
|
3,256 | $1,179,062 | |
| 6 | MRK |
Merck & Co., Inc.
|
5,318 | $683,363 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
4,006 | $506,118 | |
| 8 | PFE |
Pfizer Inc
This page
|
14,641 | $352,555 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $352,555 | 14,641 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $411,119 | 14,641 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $425,839 | 17,102 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $512,198 | 20,102 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $414,552 | 17,102 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $408,531 | 16,122 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $429,308 | 16,182 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $320,857 | 11,087 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $310,214 | 11,087 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $355,033 | 12,794 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $443,999 | 15,422 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $502,923 | 15,162 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $370,834 | 10,110 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $412,488 | 10,110 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $518,036 | 10,110 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $442,413 | 10,110 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $615,266 | 11,735 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $607,520 | 11,735 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $692,951 | 11,735 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $645,150 | 15,000 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $593,274 | 15,150 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $543,450 | 15,000 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $552,150 | 15,000 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $477,172 | 13,002 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $423,498 | 12,951 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $422,720 | 12,951 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||